320 related articles for article (PubMed ID: 34566963)
1. A Novel Treatment for Ewing's Sarcoma: Chimeric Antigen Receptor-T Cell Therapy.
Lin Z; Wu Z; Luo W
Front Immunol; 2021; 12():707211. PubMed ID: 34566963
[TBL] [Abstract][Full Text] [Related]
2. VEGFR2 as a target for CAR T cell therapy of Ewing sarcoma.
Englisch A; Altvater B; Kailayangiri S; Hartmann W; Rossig C
Pediatr Blood Cancer; 2020 Oct; 67(10):e28313. PubMed ID: 32729251
[TBL] [Abstract][Full Text] [Related]
3. Potential approaches to the treatment of Ewing's sarcoma.
Yu H; Ge Y; Guo L; Huang L
Oncotarget; 2017 Jan; 8(3):5523-5539. PubMed ID: 27740934
[TBL] [Abstract][Full Text] [Related]
4. GD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcoma.
Charan M; Dravid P; Cam M; Audino A; Gross AC; Arnold MA; Roberts RD; Cripe TP; Pertsemlidis A; Houghton PJ; Cam H
Int J Cancer; 2020 Jun; 146(11):3184-3195. PubMed ID: 31621900
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapies in Ewing's sarcoma.
Scotlandi K
Adv Exp Med Biol; 2006; 587():13-22. PubMed ID: 17163152
[TBL] [Abstract][Full Text] [Related]
6. The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors.
Grier HE
Pediatr Clin North Am; 1997 Aug; 44(4):991-1004. PubMed ID: 9286296
[TBL] [Abstract][Full Text] [Related]
7. Ewing's sarcoma and primitive neuroectodermal tumor of hand and forearm. Experience of the Cooperative Ewing's Sarcoma Study Group.
Daecke W; Ahrens S; Juergens H; Martini AK; Ewerbeck V; Kotz R; Winkelmann W; Bernd L
J Cancer Res Clin Oncol; 2005 Apr; 131(4):219-25. PubMed ID: 15614525
[TBL] [Abstract][Full Text] [Related]
8. Current Status of Proteomics in Ewing's Sarcoma.
Kondo T
Proteomics Clin Appl; 2019 May; 13(3):e1700130. PubMed ID: 29992772
[TBL] [Abstract][Full Text] [Related]
9. The treatment outcome for adult patients with Ewing's sarcoma.
Ganjoo KN; Patel S
Curr Oncol Rep; 2013 Aug; 15(4):372-7. PubMed ID: 23605781
[TBL] [Abstract][Full Text] [Related]
10. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
Uren A; Toretsky JA
Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028
[TBL] [Abstract][Full Text] [Related]
11. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of CAR T cell in malignancies: A scoping review.
Mehrabadi AZ; Ranjbar R; Farzanehpour M; Shahriary A; Dorostkar R; Hamidinejad MA; Ghaleh HEG
Biomed Pharmacother; 2022 Feb; 146():112512. PubMed ID: 34894519
[TBL] [Abstract][Full Text] [Related]
13. Primary Bone Tumors: Challenges and Opportunities for CAR-T Therapies.
Folkert IW; Devalaraja S; Linette GP; Weber K; Haldar M
J Bone Miner Res; 2019 Oct; 34(10):1780-1788. PubMed ID: 31441962
[TBL] [Abstract][Full Text] [Related]
14. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
Kinsey M; Smith R; Lessnick SL
Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
[TBL] [Abstract][Full Text] [Related]
15. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
17. Congenital Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: A Case Report and Review of the Literature.
Jin SG; Jiang XP; Zhong L
Pediatr Neonatol; 2016 Oct; 57(5):436-439. PubMed ID: 24480101
[TBL] [Abstract][Full Text] [Related]
18. Ewing's sarcoma cancer stem cell targeted therapy.
Todorova R
Curr Stem Cell Res Ther; 2014 Jan; 9(1):46-62. PubMed ID: 24294922
[TBL] [Abstract][Full Text] [Related]
19. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
20. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
